Consumerization
The sale drew mixed reactions, with some U.S. states supporting it as a privacy measure and others objecting over legal and data concerns.
Dr. Ricky Bloomfield, Oura's first CMO, spoke with MobiHealthNews about his plans for the company and his vision to personalize Oura's offerings using generative AI.
The company has secured 510(k) clearance for its Apple Watch-powered seizure monitoring platform, expanding the role of wearables in epilepsy care.
The company touts that it recently surpassed 2.5 million rings sold and has seen its member base and revenue more than double over the past year.
The company says 510(k) clearance will allow it to pursue multiple business opportunities pertaining to remote patient monitoring and clinical trials.
The investment brings Oura's valuation to more than $5 billion. The partnership enables a two-way data flow between the Oura Ring and Dexcom's continuous glucose monitor.
Last week, the wearables company announced it opened an investigation into apparent manipulation in trading its common shares following a 1-for-15 reverse stock split.
The acquisition of data company Sparta Science will allow Oura to expand its data analytics capabilities and its B2B offerings.
A J.D. Power study indicates patients are more satisfied with payer-provided telehealth offerings and less pleased with direct-to-consumer telehealth providers compared to a year ago.
The technology marries advanced proficiency of full prescription hearing aids with the contemporary design of consumer earbuds.